Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03271151 · ClinicalTrials.gov registry record · Phase 4
Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
NCT03271151 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 160 participants.
The verdict
NCT03271151, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
Study Summary
Post-discharge pain after total knee arthroplasty remains problematic; many patients have excessive pain at the 2 week time point (and often thereafter). Reduction in opioid use has become a national goal, due to the 'epidemic' in opioid misuse. In addition to enrolling non-opioid users, we will enroll up to 15 chronic opioid users.
Interventions
- OTHER Placebo
- DRUG Cymbalta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2017-09-28 |
| Est. Completion | 2021-02-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03271151
The ClinicalTrials.gov registry entry for NCT03271151 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03271151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03271151 about?
NCT03271151 is a clinical study titled "Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty". Post-discharge pain after total knee arthroplasty remains problematic; many patients have excessive pain at the 2 week time point (and often thereafter). Reduction in opioid use has become a national goal, due to the 'epidemic' in opioid misuse. In addition to enrolling non-opioid users, we will en...
What is the current status of trial NCT03271151?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2017-09-28. Estimated completion is 2021-02-19.
What interventions are being tested in trial NCT03271151?
The interventions under investigation include: Placebo (OTHER), Cymbalta (DRUG).
Who is sponsoring clinical trial NCT03271151?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.